Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

The True Post icon

Markers released top-line results today after previously reporting the trial succeeded.

Source: Ars Technica

Share This Article
The newsroom of The True Post.
Leave a Comment